Diabetes Digital Health

Diabetes Digital Health

2020, Pages 51-63
Diabetes Digital Health

Chapter 4 - Agile science: what and how in digital diabetes research

https://doi.org/10.1016/B978-0-12-817485-2.00004-3Get rights and content

Abstract

The agile method is a specific approach to project management for developing products rapidly and iteratively. Teams using an agile approach use principles and tools that involve inputs from end users, iterations on an idea, and frequent structured communication among all team members. Work is delivered more quickly with more appeal to end users and, ultimately, more value. In this chapter, we discuss how to apply an agile methodology to research involving digital health interventions and present examples from our work in diabetes self-management support interventions. In traditional models of scientific research, processes are often slow and outcomes evaluation can be hindered by ineffective products or solutions. We highlight the benefits of applying agile methods to research such that teams can operate efficiently and learn quickly about the best course of action to maximize the likelihood of a successful project.

References (0)

Cited by (4)

  • Disparities in digital health in underserved populations

    2022, Diabetes Digital Health and Telehealth
  • Retaining diverse adults with diabetes in a long-term trial: Strategies, successes, and lessons learned

    2021, Contemporary Clinical Trials
    Citation Excerpt :

    We implemented several strategies throughout a 15-month randomized controlled trial (RCT) to encourage retention among a diverse patient sample with type 2 diabetes (T2D) and monitored participants' use of the strategies to determine their relative success. Our research and selection of retention strategies were informed by community-engaged research practices (which include reciprocal relationships and clear frequent communications with our clinic partners) [18] and agile methods (which require iterative improvements based on feedback from target users - in this case, patients and clinic staff) [19]. Our goals for the study did not include formal development and testing of retention strategies; rather our goals were to conduct a rigorous high-quality trial, ensure representation of minoritized and historically underrepresented groups for whom and with whom the interventions were designed, and form and maintain positive relationships with clinic partners.

View full text